Built for Shared Success

Shared Risk, Shared Reward, and Long-Term Discovery Success

Some discovery goals demand more than transactional engagements. X-Chem’s strategic collaboration model creates integrated, long-term partnerships for organizations advancing multiple discovery programs. These collaborations emphasize shared risk, tailored milestones, and mutual investment in your pipeline’s success.

Strategic collaborations provide more than hits or leads. They deliver optimized, nomination-ready candidates across multiple programs to drive sustained pipeline growth.

Why Discovery Teams Choose Strategic Collaboration

True Risk-Sharing

Your goals are our goals. We succeed when you succeed. Payment terms and discovery milestones are explicitly tied to your program’s advancement, ensuring alignment at every stage.

Customized for Long-Term Impact

Tailored milestone structures, flexible program design and comprehensive discovery capabilities deliver a powerful engine for sustained pipeline development.

Transparency and Integration

You’ll work side by side with a dedicated, cross-functional X-Chem team, ensuring consistency, rapid decision-making and a fully transparent discovery process.

Proven Discovery Engine

Your programs leverage the complete power of X-Chem’s discovery platform, proven across multiple therapeutic areas and numerous development-stage candidates.

Who Benefits Most from Strategic Collaboration?

This partnership is specifically built for organizations seeking long-term discovery growth and strategic alignment.

  • Companies scaling R&D pipelines and managing multiple targets
  • Organizations building a focused therapeutic pipeline without extensive internal infrastructure
  • Discovery teams that prefer one deeply integrated partner rather than fragmented engagements
  • Programs requiring clear accountability, fully transparent planning, and joint risk sharing

A True Shared-Risk Structure

We stand fully behind our collaborative model, aligning payment terms and commitments directly to program success. Your risk is our risk. Our incentives are completely aligned with your outcomes. We follow the science – together.

  • If we cannot deliver on a defined stage or milestone, the project pauses without additional obligation.
  • If your strategic priorities shift, completed investments can be reallocated toward other programs, preserving your resources and flexibility.

End-to-End Pipeline Partnership

With an X-Chem strategic collaboration, you commit to two or more CandidateBuilder-level programs to advance multiple targets simultaneously or in sequence. This model integrates seamlessly across your pipeline, delivering efficiency, clarity, and continuity.

Complete Discovery Workflow

End-to-end support, from DEL screening and computational modeling through iterative medicinal chemistry, ADME/DMPK optimization and nomination-ready candidate packages.

Multi-Program Commitment

Advance multiple targets, scaled to your pipeline needs, with the flexibility to choose preferred endpoints and outcomes.

Custom Milestones and Flexible Terms

Payment structures customized to your objectives, typically mirroring individual CandidateBuilder programs but adjusted for your scale and complexity.

Shared Planning and Complete Transparency

Jointly developed strategies, clearly defined success criteria and open access to data and decision-making every step of the way.

Let’s Build Your Pipeline Together

A strategic collaboration with X-Chem isn’t just about discovery support. It’s about aligning vision, sharing risks and accelerating outcomes.

Ready to build a robust, sustainable pipeline with a partner as invested in your success as you are?

Contact us today, and let’s explore the possibilities.